Pharmaceutical - Daiichi Sankyo, Bristol-Myers Squibb


Popular Filters

Brazil's atrial fibrillation market to grow at 31% annually over the next five years


The Brazilian market for atrial fibrillation will increase at a rate of 31% per year from 2011 to 2016,…

BayerBoehringer IngelheimBristol-Myers SquibbCardio-vascularDaiichi SankyoEliquisLixianaMarkets & MarketingPfizerPharmaceuticalPradaxaPricingSouth AmericaXarelto

Anti-clotting drugs prasugrel and clopidogrel yield similar results


The TRILOGY ACS study, the first trial to study patients with acute coronary syndrome who do not undergo…

Bristol-Myers SquibbCardio-vascularDaiichi SankyoEffientEli LillyPharmaceuticalPlavixResearchSanofi

Back to top